Neuropace Stock Forward View - Accumulation Distribution
| NPCE Stock | USD 13.36 -0.02 -0.15% |
Neuropace's Accumulation Distribution reference page covers the model's projected value and error measures from recent price data. The forecast output and associated deviation metrics are shown for informational use. The model is fitted to available historical daily prices for Neuropace. This page is updated as new daily closing prices become available for Neuropace.
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume All Accumulation Distribution forecast figures shown for Neuropace are reference data reflecting model output based on available historical prices. Accumulation Distribution Analysis Today
Neuropace has current Accumulation Distribution of 0. The accumulation distribution (A/D) indicator shows the degree to which Neuropace is accumulated by the market over a given period. It uses the quote sensitivity to the highest or lowest daily price of Neuropace to determine if accumulation or reduction is taking place in the market. This value is adjusted by Neuropace trading volume to give more weight to distributions with higher volume over lower volume.| Volatility | Backtest | Information Ratio |
Neuropace Trading Date Momentum
| On March 24 2026 Neuropace was traded for 13.36 at the closing time. The top price for the day was 13.36 and the lowest listed price was 13.36 . There was no trading activity during the period. Lack of trading volume on March 24, 2026 did not cause price change. The trading delta at closing time against the current closing price is 0.15% . |
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
| Compare Neuropace to competition |
Other Forecasting Options for Neuropace
Bollinger Bands applied to Neuropace Stock price data measure how far Neuropace has deviated from its recent average relative to its own volatility. This distinction drives the choice of forecasting model applied to Neuropace's price data. On-balance volume for Neuropace Stock creates a running indicator of buying versus selling pressure in Neuropace. Price departures from the channel boundary often mean-revert, offering tactical signals for Neuropace's.Neuropace Related Equities
Sizing up Neuropace against these stocks within the Health Care space shows how it compares on key financial measures. Key comparison metrics include price-to-earnings, profit margin, and revenue growth across Neuropace's peer group. Identifying peers that steadily beat or lag Neuropace across many periods highlights durable competitive gaps. These checks provide a starting point for deeper study of Neuropace's strengths and weak spots.
| Risk & Return | Correlation |
Neuropace Market Strength Events
For investors tracking Neuropace, market strength indicators offer quantitative evaluation of stock behavior. These indicators add context to timing decisions around Neuropace positions. These indicators capture shifts in momentum that may precede significant price moves in Neuropace. These metrics provide actionable context for both entry and risk management decisions around Neuropace.
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 13.36 | |||
| Day Typical Price | 13.36 | |||
| Price Action Indicator | -0.01 | |||
| Period Momentum Indicator | -0.02 | |||
| Relative Strength Index | 40.83 |
Neuropace Risk Indicators
Analyzing Neuropace's basic risk indicators provides investors with a structured view of the risk-return trade-off for neuropace stock. By identifying the level of risk embedded in Neuropace's investment, investors can make informed decisions about position sizing. Analyzing Neuropace's risk indicators gives investors important context for price forecasting. Understanding the risk in Neuropace's investment allows investors to make informed choices about mitigating exposure.
| Mean Deviation | 2.05 | |||
| Standard Deviation | 2.53 | |||
| Variance | 6.42 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Neuropace
A coverage review of Neuropace shows when the security is attracting above-average attention from contributors and market observers. This is most useful when investors want to understand why a security is suddenly drawing more public discussion.
Contributor Headline
Latest Perspective From Macroaxis
Neuropace Short Properties
Short sentiment tied to Neuropace matters because heavier bearish pressure can change how quickly future price expectations become unstable. The stronger read compares short sentiment with trend behavior, volume, and the broader market narrative.
| Common Stock Shares Outstanding | 32.7 M | |
| Cash And Short Term Investments | 61.1 M |